期刊文献+

马钱子碱对乳腺癌骨转移相关因子表达的影响 被引量:9

Effects of Brucine on Correlated Factors Expression in Breast Cancer with Bone Metastasis
原文传递
导出
摘要 [目的]探讨马钱子碱对乳腺癌骨转移相关因子的影响。[方法]建立裸鼠乳腺癌骨转移的模型,并用马钱子碱干预后用逆转录聚合酶链反应法(RT-PCR)检测各组肿瘤组织中骨转移相关因子MMP-2、CXCR4、RANKL、OPG m RNA表达量。[结果]马钱子碱经腹腔给药的半数致死量(Medial lethal dose,LD_(50))为69mg/kg。根据LD50的1/10、1/20和1/40的量,设三个剂量组:高剂量组6.90mg/kg1、中剂量组3.45mg/kg和低剂量组1.73mg/kg,同时与空白对照组比较。马钱子碱各剂量组MMP-2,CXCR4,RANKL m RNA的表达量随着马钱子碱剂量的增加逐渐下降(P<0.05),而OPG m RNA的表达量则随着马钱子碱剂量的增加逐渐增加(P<0.05)。[结论 ]马钱子碱可以抑制乳腺癌骨转移,主要以调节MMP-2、CXCR4、RANKL、OPG等骨转移相关因子的表达为主要手段。 [Objective] To explore the effect of brucine on bone metastasis factors in breast cancer. [Methods] Model of breast cancer bone metastasis in nude mice was made,bone metastasis correlation factors expression of MMP-2,CXCR4,RANKL,OPG m RNA after Brucine intervention were detected by RT-PCR method. [Results] The median lethal dose(LD(50)) of brucine by intraperitoneal administration was 69 mg/kg. According to LD50 and 1/10,1/20 and 1/40,the experiment group was divided into high dose group(6.90 mg/kg),middle dose group(3.45 mg/kg),low dose group(1.73 mg/kg) and control group. The MMP-2,CXCR4,RANKL m RNA expression decreased with Brucine dose increased(P 0.05), While the expression of OPG m RNA increased with Brucine dose increased(P〈0.05). [Conclusion ]Brucine can inhibit bone metastasis of breast cancer,mainly in regulating bone metastasis-associated factors such as MMP-2,CXCR4,RANKL,OPG as the main means of expression.
出处 《肿瘤学杂志》 CAS 2017年第12期1093-1097,共5页 Journal of Chinese Oncology
基金 安徽省卫生计生委中医药科研课题(2014zy18)
关键词 马钱子碱 MMP-2 CXCR4 RANKL OPG mRNA brucine MMP-2 CXCR4 RANKL OPG mRNA
  • 相关文献

参考文献4

二级参考文献46

  • 1高娜,茆俊卿,张育,李国青,周玮,沈维干,顾健.士的宁对K562/A02细胞经典及非经典多药耐药机制作用的实验研究[J].中药药理与临床,2008,24(5):29-32. 被引量:2
  • 2Thakur A,Sun Y,Bollig A,et al.Anti-invasive and An- timetastatic activities of ribosomal protein s6 kinase 4 in breast cancer cells [J].Clin Cancer Res,2008,14(14): 4427-4436.
  • 3Preusser M,Heinzl H,Gelpi E,et al. Ki-67 index in in-tracranialependymoma :a promising histopathological can- didate biomarker[J]. Histopathology, 2008,53(1) : 39-47.
  • 4Jirstrom K,Stendahl M,Ryden L,et al. Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclinD1 gene amplification [J]. Cancer Res,2005,65: 8009-8016.
  • 5Han S,Park K,Bae BN,et al. Prognostic implication of cyclinE expression and its relationshop with cyclinSl and p27 kepl expression on tissur microarrays of node nega- tive breast cancer[J]. J Surg Oncol, 2003,83(4) : 241-247.
  • 6Shadidi KR, Aarvak T, Henriksen JE, et al. The chemoki- nesCCL5 ,CCL2 and CXCL12 play significant roles in the migration of Thl cells into rheumatoid synovial tissue [J]. Scand J Immunol, 2003,57(2) : 192-198.
  • 7Kato M, Kitayama J, Kazama S,et al. Expression paRem of CXC chemokine receptor-d is correlated with 1 ymph node metastasis in human invasive ductal carcinoma [J]. Breast Cancer Res, 2003,5(5) : 144-150.
  • 8Park SW,Chung NG,Hur SY,et al. Mutational analysis of hypoxia-related genes HIFI alpha and CUL2 in common human cancers[J]. APMIS, 2009, Dee, 117(12) : 880-885.
  • 9Bos R,vander Groep P,Greijer AE,et al. Levels of hypox- ia inducible factor-1α independently predict prognosis in- patients with lymplmode negative breast carcinoma [J]. Cancer, 2003,97(3): 1573-1581.
  • 10Wang H,Nan L,Yu D,et aL Antisense anti-MDM2 oligonu- cleotides as a novel therapeutic approach to human breast cancer:in vitro and in vivo activities and mechanisms[J]. Clin Cancer Res, 2001,7(11) : 3613-3624.

共引文献1050

同被引文献136

引证文献9

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部